Matthew K Fust Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Matthew K Fust.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Matthew K Fust. Matthew K Fust is EVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and EVP, Chief Financial Officer in Jazz Pharmaceuticals plc ($JAZZ) and Senior Vice President & CFO in Jazz Pharmaceuticals plc ($JAZZ) and SVP and CFO in Jazz Pharmaceuticals plc ($JAZZ) and Director in MACROGENICS INC ($MGNX) and in Ultragenyx Pharmaceutical Inc. ($RARE) and Director in Ultragenyx Pharmaceutical Inc. ($RARE) and in Dermira, Inc. ($DERM) and Director in Dermira, Inc. ($DERM) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Director in Crinetics Pharmaceuticals, Inc. ($CRNX).

Latest Insider Trading Transactions of Matthew K Fust

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, ATRA, CRNX, DERM, JAZZ, MGNX, RARE

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	M	21.00	6,181	129,801	0
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	90.00	6,181	556,290	13,550	19.7 K to 13.6 K (-31.33 %)
Jul 08 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Buy	M	21.00	6,181	129,801	19,731	13.6 K to 19.7 K (+45.62 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	M	21.00	5,000	105,000	6,181
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	85.00	5,000	425,000	13,550	18.6 K to 13.6 K (-26.95 %)
Jul 06 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Buy	M	21.00	5,000	105,000	18,550	13.6 K to 18.6 K (+36.90 %)
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	76.58	4,250	325,465	4,250
Jun 30 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	2,550	0	13,550	11 K to 13.6 K (+23.18 %)
Jun 22 2020	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	A	23.23	12,500	290,375	12,500
Jun 17 2020	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	10.54	24,500	258,230	24,500
Jun 17 2020	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Grant	A	0.00	8,000	0	33,854	25.9 K to 33.9 K (+30.94 %)
May 19 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	75.00	1,875	140,625	11,000	12.9 K to 11 K (-14.56 %)
Apr 24 2020	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	65.00	1,875	121,875	12,875	14.8 K to 12.9 K (-12.71 %)
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	0.00	3,000	0	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	9.38	6,000	56,280	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	9.95	6,000	59,700	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	28.01	6,000	168,060	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	28.82	10,344	298,114	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	16.00	10,344	165,504	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	D	5.51	14,224	78,374	0
Feb 24 2020	DERM	Dermira, Inc.	Fust Matthew K		Sell	D	18.75	5,051	94,706	0	5.1 K to 0 (-100.00 %)
Dec 26 2019	DERM	Dermira, Inc.	Fust Matthew K		Sell	S	15.00	3,000	45,000	5,051	8.1 K to 5.1 K (-37.26 %)
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	M	1.91	3,500	6,685	42,092
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Sell	S	22.50	3,500	78,750	12,536	16 K to 12.5 K (-21.83 %)
Dec 18 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Buy	M	1.91	3,500	6,685	16,036	12.5 K to 16 K (+27.92 %)
Dec 13 2019	DERM	Dermira, Inc.	Fust Matthew K		Sell	S	12.00	3,000	36,000	8,051	11.1 K to 8.1 K (-27.15 %)
Sep 16 2019	DERM	Dermira, Inc.	Fust Matthew K		Sell	S	8.77	6,000	52,636	11,051	17.1 K to 11.1 K (-35.19 %)
Jul 01 2019	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	20.25	13,000	263,250	13,000
Jul 01 2019	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Grant	A	0.00	4,000	0	25,854	21.9 K to 25.9 K (+18.30 %)
Jun 25 2019	CRNX	Crinetics Pharmace ...	Fust Matthew K	Director	Option Exercise	A	23.24	12,500	290,500	12,500
Jun 14 2019	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	M	0.00	3,000	0	0
Jun 14 2019	DERM	Dermira, Inc.	Fust Matthew K		Buy	M	0.00	3,000	0	17,051	14.1 K to 17.1 K (+21.35 %)
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	58.74	5,000	293,700	5,000
Jun 13 2019	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	3,000	0	14,750	11.8 K to 14.8 K (+25.53 %)
Jun 06 2019	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	0.00	3,000	0	3,000
Jun 06 2019	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	9.38	6,000	56,280	6,000
May 20 2019	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	A	18.00	10,000	180,000	10,000
Feb 08 2019	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	M	20.15	6,924	139,519	0
Feb 08 2019	MGNX	MACROGENICS INC	Fust Matthew K	Director	Sell	S	29.38	6,924	203,427	500	7.4 K to 500 (-93.27 %)
Feb 08 2019	MGNX	MACROGENICS INC	Fust Matthew K	Director	Buy	M	20.15	6,924	139,519	7,424	500 to 7.4 K (+1,384.80 %)
Oct 19 2018	DERM	Dermira, Inc.	Fust Matthew K		Sell	S	13.75	4,000	55,000	14,051	18.1 K to 14.1 K (-22.16 %)
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	80.69	5,000	403,450	5,000
Jun 20 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	3,000	0	11,750	8.8 K to 11.8 K (+34.29 %)
Jun 18 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	45.65	5,000	228,250	5,000
Jun 18 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Grant	A	0.00	1,500	0	21,854	20.4 K to 21.9 K (+7.37 %)
Jun 14 2018	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	M	0.00	3,000	0	0
Jun 14 2018	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	0.00	3,000	0	3,000
Jun 14 2018	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	9.95	6,000	59,700	6,000
Jun 14 2018	DERM	Dermira, Inc.	Fust Matthew K		Buy	M	0.00	3,000	0	18,051	15.1 K to 18.1 K (+19.93 %)
May 30 2018	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Sell	S	72.00	6,319	454,969	8,750	15.1 K to 8.8 K (-41.93 %)
May 21 2018	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	A	21.34	10,000	213,400	10,000
May 16 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	534	0	0
May 16 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	534	0	20,354	19.8 K to 20.4 K (+2.69 %)
May 16 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Sell	S	43.57	12,286	535,301	19,820	32.1 K to 19.8 K (-38.27 %)
Feb 20 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	534
Feb 20 2018	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	32,106	30.5 K to 32.1 K (+5.26 %)
Nov 17 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,602	0	2,137
Nov 17 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,602	0	30,503	28.9 K to 30.5 K (+5.54 %)
Aug 17 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	3,739
Aug 17 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	28,901	27.3 K to 28.9 K (+5.87 %)
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	A	65.66	3,750	246,225	3,750
Jun 22 2017	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Grant	A	0.00	1,875	0	15,069	13.2 K to 15.1 K (+14.21 %)
Jun 15 2017	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	0.00	3,000	0	3,000
Jun 15 2017	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	28.01	6,000	168,060	6,000
Jun 12 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	13.20	21,500	283,800	21,500
Jun 12 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Grant	A	0.00	5,000	0	27,298	22.3 K to 27.3 K (+22.42 %)
May 22 2017	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	A	19.57	10,000	195,700	10,000
Feb 16 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	6,944
Feb 16 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	20,696	19.1 K to 20.7 K (+8.40 %)
Jan 05 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	15.08	5,500	82,940	5,500
Jan 05 2017	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Grant	A	0.00	2,000	0	19,093	17.1 K to 19.1 K (+11.70 %)
Nov 17 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,602	0	8,547
Nov 17 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,602	0	17,093	15.5 K to 17.1 K (+10.34 %)
Aug 17 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	10,149
Aug 17 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	15,491	13.9 K to 15.5 K (+11.54 %)
Jun 23 2016	DERM	Dermira, Inc.	Fust Matthew K		Option Exercise	A	28.82	10,344	298,114	10,344
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Fust Matthew K		Option Exercise	A	65.85	3,750	246,938	3,750
Jun 14 2016	RARE	Ultragenyx Pharmac ...	Fust Matthew K		Grant	A	0.00	1,875	0	13,194	11.3 K to 13.2 K (+16.57 %)
May 20 2016	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	A	21.06	8,500	179,010	8,500
May 18 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,602	0	11,752
May 18 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,602	0	13,888	12.3 K to 13.9 K (+13.04 %)
Feb 18 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	13,354
Feb 18 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	12,286	10.7 K to 12.3 K (+15.01 %)
Jan 05 2016	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	A	24.05	10,500	252,525	10,500
Nov 18 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,602	0	14,957
Nov 18 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,602	0	10,683	9.1 K to 10.7 K (+17.64 %)
Aug 19 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	1,603	0	16,559
Aug 19 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	1,603	0	9,081	7.5 K to 9.1 K (+21.44 %)
Jun 30 2015	DERM	Dermira, Inc.	Fust Matthew K	Director	Option Exercise	M	5.51	9,051	49,871	14,224
Jun 30 2015	DERM	Dermira, Inc.	Fust Matthew K	Director	Buy	M	5.51	9,051	49,871	15,051	6 K to 15.1 K (+150.85 %)
Jun 22 2015	RARE	Ultragenyx Pharmac ...	Fust Matthew K		Option Exercise	A	97.85	7,500	733,875	7,500
Jun 15 2015	DERM	Dermira, Inc.	Fust Matthew K	Director	Option Exercise	A	16.00	10,344	165,504	10,344
May 21 2015	MGNX	MACROGENICS INC	Fust Matthew K	Director	Option Exercise	A	32.34	8,500	274,890	8,500
May 19 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Option Exercise	M	0.00	7,478	0	18,162
May 19 2015	ATRA	Atara Biotherapeut ...	Fust Matthew K	Director	Buy	M	0.00	7,478	0	7,478	0 to 7.5 K
Mar 23 2015	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Option Exercise	M	21.00	6,319	132,699	11,181
Mar 23 2015	RARE	Ultragenyx Pharmac ...	Fust Matthew K	Director	Buy	M	21.00	6,319	132,699	11,319	5 K to 11.3 K (+126.38 %)
Dec 01 2008	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	EVP, Chief Financia ...	Buy	J	1.28	379	485	58,948	58.6 K to 58.9 K (+0.65 %)
Jun 02 2008	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	EVP and CFO	Buy	J	6.50	1,203	7,820	58,569	57.4 K to 58.6 K (+2.10 %)
May 19 2008	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	EVP and CFO	Option Exercise	A	7.96	60,000	477,600	60,000
May 19 2008	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	EVP and CFO	Grant	A	0.00	6,281	0	57,366	51.1 K to 57.4 K (+12.30 %)
Dec 03 2007	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	SVP and CFO	Buy	J	13.18	1,388	18,294	51,085	49.7 K to 51.1 K (+2.79 %)
Jun 06 2007	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	Senior Vice Preside ...	Option Exercise	C	0.00	19,879	0	0
Jun 06 2007	JAZZ	Jazz Pharmaceutica ...	Fust Matthew K	Senior Vice Preside ...	Buy	C	0.00	19,879	0	49,697	29.8 K to 49.7 K (+66.67 %)

Page: 1